These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29992382)

  • 1. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
    Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
    Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway.
    Do Carmo H; Arjun S; Petrucci O; Yellon DM; Davidson SM
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):165-168. PubMed ID: 29582211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Highly Selective Caspase-1 Inhibitor VX-765 Provides Additive Protection Against Myocardial Infarction in Rat Hearts When Combined With a Platelet Inhibitor.
    Yang XM; Downey JM; Cohen MV; Housley NA; Alvarez DF; Audia JP
    J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):574-578. PubMed ID: 28399648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.
    Yang XM; Gadde S; Audia JP; Alvarez DF; Downey JM; Cohen MV
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):371-376. PubMed ID: 30744423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
    Yang XM; Cui L; Alhammouri A; Downey JM; Cohen MV
    Cardiovasc Drugs Ther; 2013 Oct; 27(5):403-12. PubMed ID: 23832692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR; Braczko F; Gedik N; Stroetges M; Heusch G; Kleinbongard P
    Basic Res Cardiol; 2021 Apr; 116(1):27. PubMed ID: 33876304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrially targeted Endonuclease III has a powerful anti-infarct effect in an in vivo rat model of myocardial ischemia/reperfusion.
    Yang XM; Cui L; White J; Kuck J; Ruchko MV; Wilson GL; Alexeyev M; Gillespie MN; Downey JM; Cohen MV
    Basic Res Cardiol; 2015 Mar; 110(2):3. PubMed ID: 25595210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet P2Y₁₂ blockers confer direct postconditioning-like protection in reperfused rabbit hearts.
    Yang XM; Liu Y; Cui L; Yang X; Liu Y; Tandon N; Kambayashi J; Downey JM; Cohen MV
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):251-62. PubMed ID: 23233653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
    J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
    Vessey DA; Li L; Honbo N; Karliner JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
    Barrabés JA; Inserte J; Mirabet M; Quiroga A; Hernando V; Figueras J; Garcia-Dorado D
    Thromb Haemost; 2010 Jul; 104(1):128-35. PubMed ID: 20431845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA; Li L; Kelley M
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H881-7. PubMed ID: 21685263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
    Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
    Cells; 2021 May; 10(5):. PubMed ID: 34067674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P2Y12 antagonists and cardiac repair post-myocardial infarction: global and regional heart function analysis and molecular assessments in pigs.
    Vilahur G; Gutiérrez M; Casani L; Lambert C; Mendieta G; Ben-Aicha S; Capdevila A; Pons-Lladó G; Carreras F; Carlsson L; Hidalgo A; Badimon L
    Cardiovasc Res; 2018 Dec; 114(14):1860-1870. PubMed ID: 30124783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Ubaid S; Ford TJ; Berry C; Murray HM; Wrigley B; Khan N; Thomas MR; Armesilla AL; Townend JN; Khogali SS; Munir S; Martins J; Hothi SS; McAlindon EJ; Cotton JM
    Thromb Haemost; 2019 Jul; 119(7):1171-1181. PubMed ID: 31129911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M; Christoph I; Behmenburg F; Raupach A; Bunte S; Senpolat S; Heinen A; Hollmann MW; Mathes A; Huhn R
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):106-111. PubMed ID: 29787401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
    Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.